Description:
A type of treatment that helps the body’s immune system recognize and destroy cancer cells that have GD2 on their surface. GD2 is an antigen that is found in high levels on some types of cancer cells, such as neuroblastoma cells. Anti-GD2 monoclonal antibodies bind to GD2 on the cancer cells, which causes them to die. Some anti-GD2 monoclonal antibodies are being used in the treatment of neuroblastoma.
